|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.19 EUR | -0.90% |
|
-2.89% | -3.06% |
| 10/04 | SANOFI : JP Morgan is Neutral | ZD |
| 10/04 | SANOFI : UBS reaffirms its Neutral rating | ZD |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Biopharma | - | - | 4.12TCr | 4.39TCr | 4.62TCr | |||||
CAPEX | - | - | -290.6Cr | -319.5Cr | -176.2Cr | |||||
Operating Income | - | - | 1.12TCr | 1.13TCr | 1.21TCr | |||||
Consumer Healthcare | 452.3Cr | 514.2Cr | 523.2Cr | - | - | |||||
CAPEX | -7.9Cr | -9.8Cr | -12Cr | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Operating Income | 149.3Cr | 181Cr | 143.8Cr | - | - | |||||
Pharmaceuticals Excl. Consumer Healthcare | 2.72TCr | 3.13TCr | - | - | - | |||||
CAPEX | -147.4Cr | -148.8Cr | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Operating Income | 940.9Cr | 1.1TCr | - | - | - | |||||
Vaccines | 741.8Cr | 889.5Cr | - | - | - | |||||
CAPEX | -49Cr | -62Cr | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Operating Income | 260.9Cr | 316.8Cr | - | - | - | |||||
Pharmaceuticals | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Veterinary Drugs | ||||||||||
Others | - | 70L | - | 34Cr | 49Cr | |||||
Operating Income | -279.7Cr | -298.1Cr | -1.5Cr | 5.8Cr | 2.6Cr | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 1.44TCr | 1.83TCr | 1.85TCr | 2TCr | 2.22TCr | |||||
Total Assets | 223.4Cr | 245.7Cr | 232.2Cr | 2.11TCr | 2.29TCr | |||||
Rest of The World | 785Cr | 838.6Cr | 1.35TCr | 1.21TCr | 966Cr | |||||
Total Assets | 223.2Cr | 242.5Cr | 208.6Cr | 274.1Cr | 241.4Cr | |||||
Europe (Excluding France) | - | - | 801.3Cr | 721.3Cr | 745.9Cr | |||||
Total Assets | 976.5Cr | 874.7Cr | 814Cr | 574.5Cr | 773.1Cr | |||||
China | 272Cr | 312.3Cr | - | - | 262.1Cr | |||||
Total Assets | - | - | - | - | 12Cr | |||||
France | - | - | 237.9Cr | 181.4Cr | 171Cr | |||||
Total Assets | 325.3Cr | 287.5Cr | 308.5Cr | 311.2Cr | 312.3Cr | |||||
Europe (Excl. Russia) | 975.9Cr | 999.9Cr | - | - | - | |||||
Russia | 58Cr | 67Cr | - | - | - | |||||
Brazil | 82Cr | 93Cr | - | - | - | |||||
South Korea | - | - | - | - | - | |||||
Asia (Excl. South Asia) | - | - | - | - | - | |||||
Total Assets | 4.81TCr | 4.99TCr | 4.94TCr | 4.34TCr | - | |||||
Africa, Middle East and South Asia | - | - | - | - | - | |||||
Eurasia | - | - | - | - | - | |||||
Africa, Middle East | - | - | - | - | - | |||||
Asia | - | - | - | - | - | |||||
Other Emerging Markets | - | - | - | - | - | |||||
North America (Excluding United States) | - | - | 70Cr | - | - | |||||
Total Assets | 1.4TCr | 1.5TCr | 1.88TCr | - | - | |||||
Latin America | - | - | - | - | - | |||||
Japan | 165.7Cr | 161.3Cr | - | - | - | |||||
Europe | - | - | - | - | - |
- Stock Market
- Equities
- SAN Stock
- Financials Sanofi
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















